MedImmune

E108402

MedImmune is a biotechnology company best known as the biologics research and development arm of AstraZeneca, focusing on innovative therapies such as vaccines and monoclonal antibodies.

All labels observed (2)

Label Occurrences
MedImmune canonical 1
MedImmune, LLC 1

How this entity was disambiguated

Statements (47)

Predicate Object
instanceOf biopharmaceutical company
biotechnology company
acquiredBy AstraZeneca
acquisitionType wholly owned subsidiary
acquisitionYear 2007
alternativeName MedImmune
surface form: MedImmune, LLC
collaboratesWith academic research institutions
biotechnology companies
pharmaceutical companies
country United States of America
surface form: United States
developed Synagis
focusesOn biologics research and development
innovative therapies
monoclonal antibodies
vaccines
foundedBy Wayne T. Hockmeyer NERFINISHED
hasResearchCenterIn Cambridge, England
surface form: Cambridge, United Kingdom

Gaithersburg
surface form: Gaithersburg, Maryland

Mountain View, California, United States
surface form: Mountain View, California
headquartersCountry United States of America
surface form: United States
headquartersLocation Gaithersburg
surface form: Gaithersburg, Maryland
industry biotechnology
pharmaceuticals
notableProduct Synagis
operatesAs biologics R&D unit of AstraZeneca
parentCompany AstraZeneca
researchArea autoimmune diseases
inflammatory diseases
influenza vaccines
oncology immunotherapies
respiratory syncytial virus (RSV)
roleWithinParent biologics research and development arm of AstraZeneca
specializesIn autoimmune and inflammatory disease biologics
infectious disease therapies
oncology biologics
respiratory disease therapies
subsidiaryOf AstraZeneca
SynagisIndication prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in high-risk pediatric patients
technologyPlatform monoclonal antibody technology
vaccine technology
therapeuticArea autoimmune and inflammatory diseases
infectious diseases
oncology
respiratory diseases
therapeuticModality monoclonal antibodies
recombinant proteins
vaccines

How these facts were elicited

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

Granta Park hasTenant MedImmune
MedImmune alternativeName MedImmune
this entity surface form: MedImmune, LLC